Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Nutt, David
1998.
Substance-P antagonists: a new treatment for depression?.
The Lancet,
Vol. 352,
Issue. 9141,
p.
1644.
Anderer, Peter
Saletu, Bernd
and
Pascual-Marqui, Roberto D.
2000.
Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA).
Psychiatry Research: Neuroimaging,
Vol. 100,
Issue. 2,
p.
81.
Schmidt, Norman B.
Storey, Julie
Greenberg, Benjamin D.
Santiago, Helen T.
Li, Qian
and
Murphy, Dennis L.
2000.
Evaluating gene × psychological risk factor effects in the pathogenesis of anxiety: A new model approach..
Journal of Abnormal Psychology,
Vol. 109,
Issue. 2,
p.
308.
Schaffer, Ayal
Levitt, Anthony J
Bagby, R Michael
Kennedy, Sidney H
Levitan, Robert D
and
Joffe, Russell T
2000.
Suicidal Ideation in Major Depression: Sex Differences and Impact of Comorbid Anxiety.
The Canadian Journal of Psychiatry,
Vol. 45,
Issue. 9,
p.
822.
Sandford, John J
Argyropoulos, Spilios V
and
Nutt, David J
2000.
The psychobiology of anxiolytic drugs.
Pharmacology & Therapeutics,
Vol. 88,
Issue. 3,
p.
197.
Argyropoulos, Spilios V
Sandford, John J
and
Nutt, David J
2000.
The psychobiology of anxiolytic drugs.
Pharmacology & Therapeutics,
Vol. 88,
Issue. 3,
p.
213.
Baldwin, David S.
and
Birtwistle, Jon
2000.
Anxiolytics.
p.
55.
Breslau, N.
Schultz, L.R.
Stewart, W.F.
Lipton, R.
and
Welch, K.M.A.
2001.
Headache types and panic disorder.
Neurology,
Vol. 56,
Issue. 3,
p.
350.
Argyropoulos, Spilios V.
Bell, Caroline J.
and
Nutt, David J.
2001.
BRAIN FUNCTION IN SOCIAL ANXIETY DISORDER.
Psychiatric Clinics of North America,
Vol. 24,
Issue. 4,
p.
707.
Rausch, Jeffrey L.
Hobby, H. Mac
Shendarkar, Nitin
Johnson, Maria E.
and
Li, Junqing
2001.
Fluvoxamine Treatment of Mixed Anxiety and Depression: Evidence for Serotonergically Mediated Anxiolysis.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 2,
p.
139.
Brambilla, Francesca
2001.
Aetiopathogenesis and Pathophysiology of Bulimia Nervosa.
CNS Drugs,
Vol. 15,
Issue. 2,
p.
119.
Bell, Caroline
Abrams, Jolane
and
Nutt, David
2001.
Tryptophan depletion and its implications for psychiatry.
British Journal of Psychiatry,
Vol. 178,
Issue. 5,
p.
399.
Antony, M.M.
2001.
International Encyclopedia of the Social & Behavioral Sciences.
p.
11015.
Feetam, Celia
2002.
Case Studies in Psychopharmacology.
p.
141.
Fukuda, K.
2002.
Possible mechanisms of panic attack and schizophrenia via APUD system.
Medical Hypotheses,
Vol. 58,
Issue. 2,
p.
123.
Schruers, Koen
van Diest, Rob
Overbeek, Thea
and
Griez, Eric
2002.
Acute l-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients.
Psychiatry Research,
Vol. 113,
Issue. 3,
p.
237.
Swain, J.
Koszycki, D.
Shlik, J.
and
Bradwejn, J.
2002.
Anxiety Disorders.
p.
269.
Pélissolo, A.
André, C.
Pujol, H.
Yao, S. N.
Servant, D.
Braconnier, A.
Orain‐Pélissolo, S.
Bouchez, S.
and
Lépine, J.‐P.
2002.
Personality dimensions in social phobics with or without depression.
Acta Psychiatrica Scandinavica,
Vol. 105,
Issue. 2,
p.
94.
Argyropoulos, S.V.
and
Nutt, D.J.
2002.
Anxiety Disorders.
p.
181.
Bell, Caroline
Forshall, Sam
Adrover, Mariona
Nash, Jon
Hood, Sean
Argyropoulos, Spilios
Rich, Ann
and
Nutt, David J.
2002.
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
Journal of Psychopharmacology,
Vol. 16,
Issue. 1,
p.
5.
eLetters
No eLetters have been published for this article.